1、OMICS Group,Contact us at: contact.omicsomicsonline.org,OMICS Group International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 400 leading-edge peer reviewed Open Access Journals and organizes over 300
2、International Conferences annually all over the world. OMICS Publishing Group journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities that ensure a rapid, quality and quick review proces
3、s. OMICS Group signed an agreement with more than 1000 International Societies to make healthcare information Open Access.,OMICS Group welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best possible way. OMICS Journals are
4、poised in excellence by publishing high quality research. OMICS Group follows an Editorial Manager System peer review process and boasts of a strong and active editorial board. Editors and reviewers are experts in their field and provide anonymous, unbiased and detailed reviews of all submissions. T
5、he journal gives the options of multiple language translations for all the articles and all archived articles are available in HTML, XML, PDF and audio formats. Also, all the published articles are archived in repositories and indexing services like DOAJ, CAS, Google Scholar, Scientific Commons, Ind
6、ex Copernicus, EBSCO, HINARI and GALE.,For more details please visit our website: http:/omicsonline.org/Submitmanuscript.php,OMICS Journals are welcoming Submissions,Wilbert S. Aronow Professor New York Medical College USA,Biography,Wilbert S. Aronow MD is Professor of Medicine at New York Medical C
7、ollege/Westchester Medical Center, Valhalla, NY, USA. Dr. Aronow received his MD from Harvard Medical School. He has edited 12 books and is author or co-author of 1,401 papers, 249 commentaries or Letters to the Editor, and 980 abstracts and is presenter or co-presenter of 1,335 talks at meetings. D
8、r. Aronow is a Fellow of the American College of Cardiology, the American Heart Association, the American College of Physicians, the American College of Chest Physicians, the American Geriatrics Society (Founding Fellow of Western Section), and the Gerontological Society of America. He has been a me
9、mber of 103 editorial boards of medical journals, co-editor of 2 journals, deputy editor of 1 journal, executive editor of 3 journals, associate editor for 9 journals, and guest editor for 7 other medical journals.,He has received each year from 2001-2014 an outstanding teacher and researcher award
10、from the medical residents and also from the cardiology fellows at Westchester Medical Center/New York Medical College. He has received awards from the Society of Geriatric Cardiology, the Gerontological Society of America, New York Medical College, the F1000 Faculty Member of the Year Award for the
11、 Faculty of Cardiovascular Disorders in 2011 and in 2013, the Walter Bleifeld Memorial Award for distinguished contributions to clinical research from the International Academy of Cardiology in July, 2010, and a Distinguished Fellowship Award from the International Academy of Cardiology in July, 201
12、2. He has been a member of 4 national guidelines committees including being Co-Chair and first author of the 2011 American College of Cardiology/American Heart Association expert consensus document on hypertension in the elderly.,Biography Contd,Biography Contd,He is currently a member of the writin
13、g group of the American Heart Association/American College of Cardiology Foundation/American Society of Hypertension scientific statement on treatment of hypertension in the management of ischemic heart disease and is currently a member of the writing group of the American College of Cardiology Foun
14、dation/American Heart Association guideline for the management of patients with hypertension. . He was a consultant to the American College of Physicians Information and Educational Resource (PIER) on the module of aortic stenosis. He is currently a member of the Board of Directors of the American S
15、ociety of Preventive Cardiology and a member of the American College of Chest Physicians Cardiovascular Medicine and Surgery Network Steering Committee.,Research Interests,Cardiovascular Disease, Hypertension, Cardiovascular Surgery,Recent Publications,Aronow WS (2014) Abdominal Aortic Aneurysm. J C
16、lin Exp Cardiolog 5: e137. Aronow WS (2014) Therapy after Myocardial Infarction. J Gen Pract 2014 2: e106. Aronow WS (2013) Renal Sympathetic Denervation Therapy for Treatment of Resistant Hypertension. J Hypertens 3:e111.,Cardiovascular Diseases,Cerebrovascular and heart disease are the second, thi
17、rd of the leading causes of death. Years of life lost are much more than other disease. Age-specific mortality of cardiovascular disease shows that most victims are over the age of 65.,Coronary artery disease Hypertension and Stroke Congestive heart failure Peripheral vascular disease Valvular, rheu
18、matic and congenital heart disease,Examples of Cardiovascular Diseases,Risk Factors are Continuous Variables,Commonly used threshold values for current definitions,Modified from A. Rogers,Exposure levels,Prevalence of Heart Disease,Data from National Health Interview Survey in Taiwan, 2001,Source: A
19、IHW GRIM books,Age-adjusted death rates for circulatory diseases, females,1907-2003,Note: Ischaemic heart diseases not separately identified before 1940,AIHW 2010. Cardiovascular Disease Mortality, Trends at different ages.,Age-specific CHD Mortality Rates: Males,Five Dimensions Control Plan,Establi
20、shing a comprehensive prevention and control systemStrengthening educational activitiesImplementing screening and care managementProviding affordable medical careConducting relevant research and surveys,Modifiable Risk,Diabetes Chronic Kidney Disease Indigenous People,General population,At-risk indi
21、viduals and groups,CVD patients,Acute Presentation ACS Stroke,A framework for strategies,Societal Context,Prevent Modifiable Risk Variables,Prevent Recurrent Events,End-stage,Acute Care,Modified from A Tonkin, Atherosclerosis and Heart Disease, 2003,Drugs More Important than Interventions after Hear
22、t Attack?,S Setoguchi et al. JACC 2008; 51: 1247-1254,n = 21484,30 day Hazard Ratio post-MI,Factors Contributing to Decline in DeathsBetter and earlier diagnosisBetter emergency and medical careImproved drugs for specific treatmentImproved public awarenessIncreased use of preventive measures, includ
23、ing lifestyle changes,Individual Behaviour Change,Healthy eating Healthy activity Healthy weight,Environmental Change,Adapted from Puska P, 2004,Complementary Approaches to Prevention,Journal of General Practice,Journal of Primary Health Care: Open AccessJournal of Health Care : Current Reviews Jour
24、nal of General Medicine: Open AccessJournal of Family Medicine & Medical Science Research,Journal of General Practice Related Conferences,3rd International Conference on Surgery and Anesthesia 3rd International Conference on Nursing & Emergency Medicine2nd International Conference on Nursing & Healt
25、hcare,OMICS Group Open Access Membership,OMICS publishing Group Open Access Membership enables academic and research institutions, funders and corporations to actively encourage open access in scholarly communication and the dissemination of research published by their authors. For more details and benefits, click on the link below: http:/omicsonline.org/membership.php,
